Literature DB >> 22807330

Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug.

Michael J Palte1, Amy K F Davis, Nicholas A McGrath, Carol A Spiegel, Ronald T Raines.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22807330      PMCID： PMC3516917          DOI： 10.1002/cmdc.201200243

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  32 in total

1.  Ribonuclease A.

Authors:  Ronald T. Raines
Journal:  Chem Rev       Date:  1998-05-07       Impact factor: 60.622

Review 2.  A prodrug approach to improve the physico-chemical properties and decrease the genotoxicity of nitro compounds.

Authors:  Man Chin Chung; Priscila Longhin Bosquesi; Jean Leandro dos Santos
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

3.  U-3'-BCIP: a chromogenic substrate for the detection of RNase A in recombinant DNA expression systems.

Authors:  M R Witmer; C M Falcomer; M P Weiner; M S Kay; T P Begley; B Ganem; H A Scheraga
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

Review 4.  When poor solubility becomes an issue: from early stage to proof of concept.

Authors:  S Stegemann; F Leveiller; D Franchi; H de Jong; H Lindén
Journal:  Eur J Pharm Sci       Date:  2007-05-21       Impact factor: 4.384

Review 5.  Applications of polymeric nanocapsules in field of drug delivery systems.

Authors:  Xinyu Rong; Yinghua Xie; Xiaomei Hao; Tao Chen; Yingming Wang; Yuanyuan Liu
Journal:  Curr Drug Discov Technol       Date:  2011-09

Review 6.  The eight human "canonical" ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins.

Authors:  Salvatore Sorrentino
Journal:  FEBS Lett       Date:  2010-04-11       Impact factor: 4.124

7.  Inhibition of ribonuclease by diethyl pyrocarbonate and other methods.

Authors:  S L Wiener; R Wiener; M Urivetzky; E Meilman
Journal:  Biochim Biophys Acta       Date:  1972-02-15

Review 8.  Clindamycin, metronidazole, and chloramphenicol.

Authors:  M J Kasten
Journal:  Mayo Clin Proc       Date:  1999-08       Impact factor: 7.616

Review 9.  Metronidazole is still the drug of choice for treatment of anaerobic infections.

Authors:  Sonja Löfmark; Charlotta Edlund; Carl Erik Nord
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

10.  Energetics of catalysis by ribonucleases: fate of the 2',3'-cyclic phosphodiester intermediate.

Authors:  J E Thompson; F D Venegas; R T Raines
Journal:  Biochemistry       Date:  1994-06-14       Impact factor: 3.162
View more
  1 in total

Review 1.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

Authors:  Andrew J Wiemer; David F Wiemer
Journal:  Top Curr Chem       Date:  2015
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.